Xtant Medical Holdings
XTNT
13 hedge funds and large institutions have $36.1M invested in Xtant Medical Holdings in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
88% more capital invested
Capital invested by funds: $19.2M → $36.1M (+$16.9M)
0.55% less ownership
Funds ownership: 90.5% → 89.95% (-0.55%)
19% less funds holding
Funds holding: 16 → 13 (-3)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$32.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$141K |
| 2 |
TI
Telemetry Investments
New York
|
-$81.3K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$13.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3K |
| 5 |
BlackRock
New York
|
-$1.92K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $28.1M | – | – | – |
|
|
PWAM
2
Park West Asset Management
San Francisco,
California
| $3.84M | – | – | – |
|
|
TI
3
Telemetry Investments
New York
| $2.35M | -$81.3K | -27,913 | -4% |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $882K | -$141K | -48,312 | -14% |
|
|
BC
5
Bruce & Co
Chicago,
Illinois
| $558K | – | – | – |
|
|
6
Renaissance Technologies
New York
| $205K | +$32.4K | +11,113 | +20% |
|
|
BCM
7
Bridgeway Capital Management
Houston,
Texas
| $153K | – | – | – |
|
8
Morgan Stanley
New York
| $33K | – | – | – |
|
|
9
BlackRock
New York
| $29K | -$1.92K | -658 | -6% |
|
|
WEC
10
Winslow Evans & Crocker
Boston,
Massachusetts
| $4K | – | – | – |
|
|
11
Bank of America
Charlotte,
North Carolina
| – | -$13.2K | -4,525 | -99% |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$3K | -1,887 | Closed |
|
XTNT Hedge Fund Activity: Q1 2019 in Review
13 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q1 2019, worth a combined $36.1M — up 88% from $19.2M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of XTNT and 0 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $32.4K. The largest seller was Vanguard Group, cutting an estimated $141K.
- 13 institutional investors held Xtant Medical Holdings (XTNT) as of Q1 2019, down from 16 in Q4 2018.
- Funds reported $36.1M of Xtant Medical Holdings stock for Q1 2019, up 88% quarter-over-quarter.
- 0 funds opened new Xtant Medical Holdings positions in Q1 2019 and 3 closed out, a net change of -3 holders.
- The largest Xtant Medical Holdings buyer in Q1 2019 was Renaissance Technologies, an estimated $32.4K added.
- The largest Xtant Medical Holdings seller in Q1 2019 was Vanguard Group, an estimated $141K sold.
Based on aggregated 13F filings for Q1 2019.